Blood test could replace needle biopsies for bile duct cancer patients

NCT ID NCT07151118

Recruiting now Knowledge-focused Sponsor: CHA University Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study is testing whether a blood test that looks for tumor DNA (ctDNA) can find important genetic changes in people with advanced bile duct cancer. Normally, doctors need a tissue sample from the tumor, which can be hard to get. The study will enroll 100 adults in Korea and compare the blood test results with standard tissue tests. The goal is to see if the blood test can help doctors choose better treatments without needing an invasive biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHA Bundang Medical Center
RECRUITING

Seongnam-si, Gyeonggi-do, 13496, South Korea

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BILIARY TRACT CANCER